Last reviewed · How we verify
NCT04407949
Comparison of Sleep Disordered Breathing Events Detected by the CPAP Device "prismaLine" With Polysomnography
NA trial testing CPAP Treatment in Sleep Apnea Syndromes in 70 participants. Completed in 30 September 2020.
8 June 2020
Quick facts
| Lead sponsor | Institut für Pneumologie Hagen Ambrock eV |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 70 |
| Start date | 17 January 2019 |
| Primary completion | 8 June 2020 |
| Estimated completion | 30 September 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- CPAP Treatment
Conditions studied
- Sleep Apnea Syndromes — all drugs for Sleep Apnea Syndromes →
Sponsor
Institut für Pneumologie Hagen Ambrock eV
Who can join
18 and older, any sex, with Sleep Apnea Syndromes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of residual sleep disordered breathing (SDB) under continuous positive airway pressure (CPAP) therapy with comparison of the automatic detected SDB event indices from CPAP machines with manual scored polysomnography (PSG).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Reliability of respiratory event detection with continuous positive airway pressure in moderate to severe obstructive sleep apnea - comparison of polysomnography with a device-based analysis.
Richter M, Schroeder M, Domanski U, Schwaibold M, et al · · 2023 · cited 7× · PMID 36394692 · DOI 10.1007/s11325-022-02740-w
Verify or expand the search:
- PubMed search for NCT04407949
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CPAP Treatment
Trials testing the same drug.
- NCT06748703 — Optic Nerve Injury in Obstructive Sleep Apnea Patients · NA · recruiting
- NCT06554496 — XOR Levels in OSA Patients (XOR-OSA) · NA · recruiting
Other recruiting trials for Sleep Apnea Syndromes
Currently open trials in the same condition.
- NCT06578390 — Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis · NA · recruiting
- NCT07086599 — Typological Study of Sleep Pathologies During Psoriatic Rheumatism and SAPHO Syndrome: Prospective Study Within the Pari · recruiting
- NCT04399200 — Apnea, Stroke and Incident Cardiovascular Events · recruiting
- NCT04234828 — Validation of Withings Sleep for the Detection of Sleep Apnea Syndrome · active not recruiting
Other Institut für Pneumologie Hagen Ambrock eV trials
Trials by the same sponsor.
- NCT05053074 — Nasal High Flow (NHF) in COPD - Effects on Ventilation in Wakefulness · NA · completed
- NCT04090671 — Evaluation of the Multidimensional Dyspnea Profile (MDP) · NA · unknown
- NCT02399514 — Improvement of Sleep Quality by RePneu® Coils in Advanced Pulmonary Emphysema · NA · completed
- NCT01986452 — Telemonitoring of CPAP Therapy in Apoplexy Patients With OSA · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04407949 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut für Pneumologie Hagen Ambrock eV
- Last refreshed: 6 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04407949.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing